Bringing dencatistat to the clinic as fast as possible
Experienced drug developers and an international investor syndicate, with more than 50 years of collective experience in cancer treatments.
Leadership team
Saint-Genis-Pouilly and Paris





Board and investors
€38M Series C, October 2025The Series C, led by V-Bio Ventures, funds clinical proof-of-concept studies for dencatistat. An EIC grant of €2.5M supports work in CTPS2-null gynaecological cancers.
Scientific founder Prof. Alain Fischer is an internationally recognised expert in immunodeficiency genetics, awarded the Japan Prize in 2015.
- Erik Van Den BergChairman, Independent Director
- Neil Gallagher, MD, PhDIndependent Non-Executive Director
- Claus Andersson, PhDSunstone Life Science Ventures
- Thibaut RoulonBpifrance
- Walter StockingerHadean Ventures
- Ohad HammerPontifax
- Rémi DrollerKurma Partners
- Ward CapoenV-Bio Ventures
Get in touch with Step Pharma
15 rue Louis et Auguste Lumière, Technoparc du Pays-de-Gex, 01630 Saint-Genis-Pouilly, France.
Contact form